“…On the other hand these findings have also contributed in elucidating drug-induced Parkinsonism as these drugs have been shown to interfere with brain monoamine metabolism. Thus the interruption of the nigrostriatal pathway leads to a cell loss (retrograde degeneration) in the corresponding substantia nigra and an associated decrease of dopamine (DA) in the ipsilateral neostriatum (Poirier and Sourkes, 1965;Poirier et al, 1966), the latter effect most likely resulting from the loss of important enzymes involved in monoamine metabolism, namely, tyrosine hydroxylase (Goldstein et al, 1966;Poirier et al, 1969c) and DOPA (5-HTP) decarboxylase (Anden et al, 1966;Goldstein et al, 1969a;Lancaster et al, 1970). Sftnilar enzymic defects have also been disclosed in the brains from Parkinsonian patients (Lloyd and Hornykiewicz, 1970).…”